Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000963453 | SCV001110609 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000963453 | SCV001889046 | benign | not provided | 2020-01-24 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001819052 | SCV002069922 | benign | not specified | 2021-06-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000963453 | SCV004164329 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | SAMD9: BP4, BS2 |
ARUP Laboratories, |
RCV000963453 | SCV004564890 | benign | not provided | 2023-08-21 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000963453 | SCV005268823 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004553450 | SCV004744580 | likely benign | SAMD9-related disorder | 2019-11-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |